ResearcherNanjing University of Chinese MedicineActive in the last 2 years
Zhiheng Zhang
Matched on ORCID iD 0000-0003-4299-5379; OpenAlex author ID A5100680517. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 41
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 4 papers
Papers 8
- Corrigendum to "NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-I" [Drug … Co-author DOI 10.1016/j.drup.2025.101269↗
- Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. First author DOI 10.1016/j.xcrm.2024.101927↗
- ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. Co-author DOI 10.1038/s41388-025-03530-w↗
- AGR2 suppresses ferroptosis via the p53/FPN1 regulatory axis and drives therapeutic vulnerabilities in pancreatic cancer. Last author DOI 10.1038/s41419-025-08263-y↗
- NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1. Co-author DOI 10.1016/j.drup.2023.101040↗
- AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53. Co-author DOI 10.1053/j.gastro.2021.07.030↗
- Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS production and endoplasmic reticulum stress … First author DOI 10.1186/s12951-020-00687-2↗
- Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.jcmgh.2018.07.003↗
Closest collaborators
The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wenjie Zhang · 2 shared papers, 2024–2025 · strength 0.52
- Paper Corrigendum to "NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9… DOI 10.1016/j.drup.2025.101269↗
- Paper NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degr… DOI 10.1016/j.drup.2023.101040↗
- Beicheng Sun · 2 shared papers, 2024–2025 · strength 0.52
- Paper Corrigendum to "NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9… DOI 10.1016/j.drup.2025.101269↗
- Paper NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degr… DOI 10.1016/j.drup.2023.101040↗
- Christoph W. Michalski · 4 shared papers, 2018–2025 · strength 0.49
- Paper Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. DOI 10.1016/j.xcrm.2024.101927↗
- Paper ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. DOI 10.1038/s41388-025-03530-w↗
- Paper AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in… DOI 10.1053/j.gastro.2021.07.030↗
- Jorg H. Kleeff · 4 shared papers, 2018–2025 · strength 0.49
- Paper Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. DOI 10.1016/j.xcrm.2024.101927↗
- Paper ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. DOI 10.1038/s41388-025-03530-w↗
- Paper AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in… DOI 10.1053/j.gastro.2021.07.030↗
- Hongzhen Li · 3 shared papers, 2021–2025 · strength 0.43
- Paper Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. DOI 10.1016/j.xcrm.2024.101927↗
- Paper ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. DOI 10.1038/s41388-025-03530-w↗
- Paper AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in… DOI 10.1053/j.gastro.2021.07.030↗
- Shuang Nie · 3 shared papers, 2018–2025 · strength 0.40
- Paper Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. DOI 10.1016/j.xcrm.2024.101927↗
- Paper ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. DOI 10.1038/s41388-025-03530-w↗
- Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
- Ziying Jian · 3 shared papers, 2018–2025 · strength 0.40
- Paper AGR2 suppresses ferroptosis via the p53/FPN1 regulatory axis and drives therapeutic vulnerabilities in pancreatic cance… DOI 10.1038/s41419-025-08263-y↗
- Paper Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS prod… DOI 10.1186/s12951-020-00687-2↗
- Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
- Chao Fang · 2 shared papers, 2025 · strength 0.34
- Zipeng Lu · 2 shared papers, 2025 · strength 0.34
- Yifeng Sun · 2 shared papers, 2025 · strength 0.34
- Susanne Roth · 2 shared papers, 2025 · strength 0.34
- Christoph Kahlert · 2 shared papers, 2025 · strength 0.34
- Ingrid Herr · 2 shared papers, 2025 · strength 0.34
- Shanshan Shen · 3 shared papers, 2018–2025 · strength 0.33
- Paper Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. DOI 10.1016/j.xcrm.2024.101927↗
- Paper AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in… DOI 10.1053/j.gastro.2021.07.030↗
- Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
- Helmut Friess · 3 shared papers, 2018–2025 · strength 0.32
- Paper ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. DOI 10.1038/s41388-025-03530-w↗
- Paper AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in… DOI 10.1053/j.gastro.2021.07.030↗
- Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
- Xiaoping Zou · 3 shared papers, 2018–2025 · strength 0.32
- Paper ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. DOI 10.1038/s41388-025-03530-w↗
- Paper AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in… DOI 10.1053/j.gastro.2021.07.030↗
- Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
- Maximilian Reichert · 2 shared papers, 2021–2025 · strength 0.27
- André L. Mihaljević · 2 shared papers, 2021–2025 · strength 0.26
- Shi Zuo · 1 shared paper, 2025 · strength 0.22
- Tao Cheng · 2 shared papers, 2018–2020 · strength 0.18
- Paper Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS prod… DOI 10.1186/s12951-020-00687-2↗
- Paper Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.jcmgh.2018.07.003↗
- Helmut Frieß · 1 shared paper, 2025 · strength 0.18
- Xiaoping Zou · 1 shared paper, 2025 · strength 0.18
- Yoshiaki Sunami · 1 shared paper, 2025 · strength 0.18
- Zahra Dantes · 1 shared paper, 2025 · strength 0.18
- Martin Loos · 1 shared paper, 2025 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.